TRENTON, N.J. (AP) — Johnson & Johnson and two other major drugmakers say they are collaborating in a global project aimed at getting patient tests of experimental drugs up and running more quickly and efficiently.

They are each contributing to a database of doctors, hospitals and clinics vetted to participate in the complex tests needed to determine whether an experimental medicine is effective and safe.